Clinical Trials Sponsored by Azelon Pharmaceuticals

Total 19692 results

Alnylam Pharmaceuticals

Completed

A Study to Evaluate ALN-AGT01 in Patients With Hypertension

Hypertension

United Kingdom
BioCryst Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan (APeX-J)

Hereditary Angioedema, HAE

Japan
Alexion Pharmaceuticals

Completed

A Study of the Effects of Food and Age on Danicopan

Healthy

United States
Regeneron Pharmaceuticals

Completed

COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers

Healthy | Chronic Stable Illness

United States
Jazz Pharmaceuticals

Completed

A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Multiple Sclerosis | Spasticity

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis

Multiple Sclerosis | Neuropathic Pain

United Kingdom
Jazz Pharmaceuticals

Completed

A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain

Pain

United Kingdom
Jazz Pharmaceuticals

Completed

An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Alexion Pharmaceuticals

Completed

Open-label, Multiple Ascending Dose Study of Ravulizumab (ALXN1210) in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria | PNH

Korea, Republic of, Canada, France, Germany, Spain, Taiwan, United Kingdom
X4 Pharmaceuticals

Terminated

Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma

United States
Botanix Pharmaceuticals

Completed

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) (Cardigan II)

Axillary Hyperhidrosis

United States
Jazz Pharmaceuticals

Completed

A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

Epilepsy

Spain, Sweden, Netherlands
Jazz Pharmaceuticals

Completed

A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma

Cancer

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of GWP42006 in People With Focal Seizures - Part A

Epilepsy | Focal Seizures

United Kingdom, Spain, Czechia
Jazz Pharmaceuticals

Completed

An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

Epilepsy

Spain, Sweden, Netherlands
Jazz Pharmaceuticals

Completed

A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects

Epilepsy

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

United Kingdom, Romania
Jazz Pharmaceuticals

Completed

A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients

Cancer

United Kingdom, Germany
Jazz Pharmaceuticals

Completed

An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.

Healthy Subjects

United States
Jazz Pharmaceuticals

Completed

A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML

Acute Myeloid Leukemia

United States
Primus Pharmaceuticals

Terminated

EpiCeram for Skin Protection in Healthcare Workers Using Personal Protective Equipment

Irritant Contact Dermatitis

United States
Jazz Pharmaceuticals

Completed

GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes

Diabetes Mellitus, Type 2 | Dyslipidemias

United Kingdom
Processa Pharmaceuticals

Completed

A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica

Necrobiosis Lipoidica

United States
Jazz Pharmaceuticals

Completed

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Seizures | Tuberous Sclerosis Complex

United States, Spain, Australia, Poland, United Kingdom, Netherlands
Jazz Pharmaceuticals

Completed

A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)

Epilepsy | Dravet Syndrome

United States, United Kingdom
Jazz Pharmaceuticals

Completed

A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

Epilepsy

Spain, United Kingdom
Jazz Pharmaceuticals

Completed

A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder

Schizophrenia | Schizophrenia-related Psychotic Disorder

Romania, Poland, United Kingdom
Jazz Pharmaceuticals

Completed

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE3)

Epilepsy | Lennox Gastaut Syndrome

United States, Spain, France, United Kingdom
Jazz Pharmaceuticals

Completed

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Epilepsy | Dravet Syndrome

United States, Spain, Israel, Poland, Australia, Netherlands
Jazz Pharmaceuticals

Completed

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE4)

Epilepsy | Lennox-Gastaut Syndrome

United States, Poland, Netherlands
Jazz Pharmaceuticals

Completed

CX-8998 for Absence Seizures (T-WAVE)

Epilepsy

United States
Intercept Pharmaceuticals

Terminated

Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment

Liver Cirrhosis, Biliary

United States, Argentina, Spain, Belgium, Germany, Canada, Australia, Estonia, Brazil, Hungary, Italy, Lithuania
Jazz Pharmaceuticals

Completed

Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

Infantile Spasms

United States, Poland
Ferring Pharmaceuticals

Completed

A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

Infertility, Female

China
Aerie Pharmaceuticals

Completed

Study Evaluating Techniques for Measuring Tear Production (MTP)

Dry Eye Disease

United States
Dizal Pharmaceuticals

Completed

A Study of DZD2269 in Healthy Adult Participants

Healthy Volunteers

United States
Syndax Pharmaceuticals

Completed

Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

ER+ Breast Cancer

Ireland, United Kingdom
Jazz Pharmaceuticals

Completed

A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy

Narcolepsy

United States
Catabasis Pharmaceuticals

Completed

Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (PolarisDMD)

Muscular Dystrophy, Duchenne

United States, Canada, Australia, United Kingdom, Germany, Ireland, Israel, Sweden
TO Pharmaceuticals

Withdrawn

A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder

Autistic Disorder

Israel
Jazz Pharmaceuticals

Withdrawn

Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder

Post-Traumatic Stress Disorder
Dizal Pharmaceuticals

Completed

Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants

Healthy Volunteers

United States
Constellation Pharmaceuticals

Completed

ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Syndax Pharmaceuticals

Completed

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer (ENCORE301)

Breast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-Positive

United States, Czechia, Canada, Hungary, Russian Federation
Syndax Pharmaceuticals

Completed

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Neoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Endocrine Gland Neoplasms | Breast Neoplasms | Breast Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Bronchial Neoplasms | Solid... and other conditions

United States
Endo Pharmaceuticals

Completed

Histopathology Following CCH Injection

Characteristics of Subcutaneous Tissue

United States
EpiEndo Pharmaceuticals

Completed

Single and Multiple Ascending Dose Study With EP395

Adult ALL

United Kingdom
Inovio Pharmaceuticals

Terminated

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer

United States
Inovio Pharmaceuticals

Terminated

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Head Neck Cancer

United States
Jazz Pharmaceuticals

Completed

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

Veno-occlusive Disease

United States, Spain, Belgium, Australia, Italy, Israel, Japan, Korea, Republic of, France, Canada, United Kingdom, Germany, New Zealand, Turkey

3

Subscribe